Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
about
Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluentsComparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitisCorrelation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitisRandomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys.Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infectionsSingle-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904.Pharmacokinetics of ceftriaxone in humans.In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.Single-dose pharmacokinetics of ceftriaxone in infants and young children.Ceftriaxone: in vitro studies and clinical evaluationCeftriaxone (Ro 13-9904) therapy of serious infection.Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infectionPharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysisCrossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteersShort report: Ceftriaxone for cat and dog bites. Simple outpatient treatment.Antibacterial properties of the CFTR potentiator ivacaftor.Ceftriaxone versus povidone iodine in preventing wound infections following biliary surgeryPharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.Pharmacokinetics of ceftriaxone.Clinical pharmacokinetics and pharmacodynamics of tigecycline.Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic.Pharmacokinetics of cefpiramide (SM-1652) in humans.Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.Comparative in vitro activity of ceftriaxone against anaerobic bacteria.Multiple-dose pharmacokinetics of ceftazidime in cancer patients.Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man.Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
P2860
Q28366172-EB6D5AD4-7086-40E8-A085-CE05403BFB78Q30451305-3329870B-3E6B-4591-AA7A-068D680128B2Q30451339-F6D055DA-4425-4378-85D4-7993ADA93B40Q33583077-12FDF1AF-9EF4-45BA-ACC0-D328A9086917Q33694847-F84A8B0C-5256-48D8-B0CB-05AF9F3FF367Q33737351-4F50DC3D-5B50-40C9-BC6C-74FC1FB6993AQ35569392-F3A7F641-E47F-407C-95A2-4DFAF3E0E9E9Q35569544-91945C41-8077-4E3F-A4E2-88B9EC3A34D3Q35668345-192ADE41-98D9-417F-B470-FB460F58FBE1Q35672073-E3332C3F-B0BC-45CE-820D-5700A9AF3B74Q35672612-D916ED53-EA13-43CB-86FC-473F7D96EB4EQ35672864-DAA17A62-8C56-41A5-BAFE-558552B9C479Q35673633-C0B91544-1F99-42FE-AAD0-468FCBFA0628Q35712352-745CE74C-58EA-48E8-A665-95FDA475E72BQ35712560-FA7EEDAE-ACC9-4241-B7BE-849C1BF18232Q35715192-284AC8CD-E5ED-4DC9-B365-055B0B636FDBQ35718258-4DCD369D-5FAF-4B1E-B229-1DEF03A252ABQ35742444-296C6578-7D7E-4D2F-921F-8447332FC830Q35755052-6CC9B92D-D836-4B91-93D5-64B55AFC795FQ35767452-6EAAB475-1D42-4CD8-8D2D-F54650AA08EEQ36406817-33004878-387E-4F9B-9800-4B8F0BBF97DBQ36479059-9373EEE9-C035-428F-98D8-601EFAB215C5Q36815860-2993C46D-2F5C-4C4C-9C53-9EFF94DC85A9Q37008814-2F99B3BF-1893-4089-95C7-9CFD0F436015Q37381432-0CD52518-8D62-41EF-A7BD-96D90F940419Q37590845-E73C1244-1A65-419A-B8A4-6EE81329A424Q39818011-ED736957-177E-48A3-8B72-13BA05FB82E1Q39835731-1F2C4AF6-7689-465E-B2AE-E5D6B6B1EB1EQ39854506-881E83D1-DF0F-43D6-8BD5-F61BA798B8B1Q39855525-F13C69AB-515D-4EB6-8D8E-53ACA3364F00Q41933130-C4A69BF6-0AB9-435A-9C8E-A2F304724A36Q42115507-57A786A8-9FF1-44E0-A367-06DA0B61EAFFQ42115617-245BBF2F-2B0A-4748-85BB-1476C4F65794Q42176930-E3562F07-3CB0-4C15-9F31-7D85DB807288Q42177357-AE5C6B30-7564-4E5A-953E-4C0E19D41E8FQ42926858-53A35CFA-CFF7-4F41-B7EE-39D1324D3C68Q42929235-2D36612D-7B7C-40EC-A188-FE5843DA83CBQ42929968-727673F9-46C9-4A15-9656-CFA638004590Q43261700-31DBFC86-B404-4E0A-919C-7F160C6D688EQ44017978-BF93E2EE-EC43-4C3B-97F7-D0690494E205
P2860
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
@en
type
label
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
@en
prefLabel
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
@en
P2093
P2860
P304
P356
10.1128/AAC.18.2.240
P407
P577
1980-08-01T00:00:00Z